About EchoConfidence (USA)
EchoConfidence, developed by MyCardium AI, is an advanced AI-driven echocardiography solution that provides highly accurate, automated measurements for cardiac imaging. It utilizes fixed Convolutional Neural Networks (CNN) trained on over 100,000 images to offer over 100 validated measurements, ensuring comprehensive assessments of cardiac structures such as the chambers, valves, vessels, and pericardium. The platform is designed to increase efficiency in echocardiography workflows by automating analysis and enabling batch processing. It also aims to improve precision through validated AI algorithms that provide consistent, reproducible measurements across numerous cardiac parameters.
EchoConfidence is built with a “human-in-the-loop” interface, allowing clinicians to review, refine, and approve measurements, contours, and fiducial points, balancing automation with expert oversight to support diagnostic confidence. The software integrates with existing hospital systems like PACS and EHR and is compatible with various imaging devices. It has received FDA 510(k) clearance and is CE Class IIb marked, indicating its compliance with rigorous regulatory requirements for clinical use. The system is intended to assist healthcare professionals in reviewing images, making measurements, and generating reports for transthoracic echocardiograms, ultimately aiming to reduce diagnostic gaps and delays in cardiovascular care.
Focus Areas
Business Intelligence
| Technology | cloud-native, AI operating system, Convolutional Neural Networks (CNN) |
What Physicians Need to Know
For physicians, EchoConfidence (USA) offers AI-powered tools that significantly enhance efficiency and precision in cardiac imaging. The 'human-in-the-loop' design ensures that you maintain full clinical oversight, allowing adjustments to AI-generated measurements and interpretations. This means you can leverage AI for accelerated workflows and reproducible measurements across different operators and sites, while still applying your expert judgment. The seamless integration with existing PACS and EHR systems minimizes disruption to current workflows. The FDA 510(k) clearance and CE Class IIb marking provide assurance of regulatory compliance and clinical validation. For clinical trials, their core lab services offer specialized AI-enhanced analysis for both cardiac MRI and echocardiography, which can lead to faster and more cost-effective detection of treatment effects. The company's commitment to explainable AI means every fiducial point, curve, and classification is transparent and editable, fostering trust in the technology.
EchoConfidence's AI software is designed for flexible compatibility, integrating seamlessly with existing hospital systems such as PACS and EHR. It is also vendor-neutral, working with various imaging devices. MyCardium AI has partnered with Optum | Change Healthcare Enterprise Imaging Healthcare to embed their advanced cardiovascular analysis technology within enterprise imaging ecosystems, aiming for a more connected and intelligent imaging workflow.
What the Web Says
EchoConfidence (USA), also known as MyCardium AI, is a healthcare AI company specializing in cardiology AI tools for physicians, particularly advanced AI-driven echocardiography solutions. The company's product, EchoConfidence, has received FDA 510(k) clearance and is CE Class IIb marked, offering over 95% accuracy across 23 automatic view classifications and over 100 validated measurements for cardiac imaging. While specific product reviews from G2, Glassdoor, Capterra, or Reddit for EchoConfidence (USA) or MyCardium AI are not readily available, the company emphasizes its commitment to accuracy, regulatory compliance, and seamless integration with existing hospital systems.
Overall: MixedStrengths
- FDA 510(k) cleared and CE Class IIb marked, demonstrating rigorous regulatory compliance
- Offers over 95% accuracy across 23 automatic view classifications for echocardiography
- Provides over 100 validated measurements for comprehensive cardiac assessments
- Features a 'human-in-the-loop' interface, allowing users to review, refine, and approve AI-generated measurements
- Designed for flexible compatibility and seamless integration with existing hospital systems (PACS, EHR) and various imaging devices
- Developed and validated by leading clinicians in cardiovascular imaging
Limitations
- No specific product or employer reviews found on G2, Glassdoor, Capterra, or Reddit
- Limited public information regarding employee experiences or company culture from independent review sites.
- The company is relatively new, founded in April 2022, which may contribute to a lack of extensive public reviews
Based on reviews from: indeed.com, physicianaitools.com, expertini.com, trustradius.com, g2.com, mycardium.com, healthcareaiops.com, bioengineer.org, reddit.com, acs.org, jobtoday.com, manymanuals.com, manuals.plus, mdpi.com, sciontec.co.uk, qi3.co.uk, wikipedia.org
Last updated: 2026-10-29
Videos
News, demos, and interviews about EchoConfidence (USA).
Videos load interactively. If none appear, search YouTube for EchoConfidence (USA) →
Press & Coverage
Frequently Asked Questions
Comparisons
Related Companies
Caption Health, formerly known as Bay Labs and now part of GE HealthCare, is a pioneering medical artificial intelligence (AI) company dedicated to expanding access to high-quality ultrasound examinations. The company’s core offering is the Caption AI platform, which utilizes AI to guide healthcare providers, including those without extensive specialized training, in acquiring and interpreting […]
Anumana is an AI-driven health technology company dedicated to transforming cardiovascular care. Co-founded by nference and Mayo Clinic, Anumana develops software-as-a-medical-device (SaMD) solutions that leverage multimodal AI to support early detection, clinical decision-making, and intraoperative guidance across the continuum of care. The company’s portfolio includes FDA-cleared ECG-based algorithms, generative imaging applications, and real-time procedural support […]
Keya Medical Technology Co. is an international medical technology company specializing in deep learning-based AI solutions for non-invasive disease diagnosis and treatment. The company, founded in 2016, develops AI-enabled diagnostic devices that aim to enhance efficiency, accuracy, and precision in healthcare across various specialties, including cardiology, neurology, pulmonology, pathology, and surgery. [2, 4, 8, 14] […]
Siemens Medical Solutions USA, Inc., operating as Siemens Healthineers USA, is a prominent medical technology company with a rich history spanning over 175 years, dedicated to pioneering breakthroughs in healthcare. As a subsidiary of the global Siemens Healthineers AG, the company offers a comprehensive portfolio that is central to clinical decision-making across the entire healthcare […]
HeartLung.AI is a health-tech company focused on leveraging artificial intelligence for the early detection and prevention of cardiovascular disease and lung cancer. Their mission is to shift healthcare from late-stage disease treatment to earlier identification and prevention by unlocking clinically actionable information embedded within routine medical imaging. The company has developed several FDA-cleared and breakthrough-designated […]
Heartvue.ai is a healthcare AI company focused on transforming cardiovascular imaging analysis. Founded by a cardiologist with over two decades of experience in advanced cardiac imaging, the company develops AI-powered tools to make advanced cardiac imaging analysis more accessible, consistent, and efficient for healthcare systems. Their mission is to alleviate the burden of manual workflows […]